CN112957516A - Polysaccharide-based tissue adhesive medical adhesive and application thereof - Google Patents
Polysaccharide-based tissue adhesive medical adhesive and application thereof Download PDFInfo
- Publication number
- CN112957516A CN112957516A CN202110160412.1A CN202110160412A CN112957516A CN 112957516 A CN112957516 A CN 112957516A CN 202110160412 A CN202110160412 A CN 202110160412A CN 112957516 A CN112957516 A CN 112957516A
- Authority
- CN
- China
- Prior art keywords
- polysaccharide
- adhesive
- based tissue
- tissue
- medical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/043—Mixtures of macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
Abstract
The invention discloses a polysaccharide-based tissue adhesive medical adhesive and application thereof, wherein the polysaccharide-based tissue adhesive medical adhesive consists of a polysaccharide derivative and a compound with at least two reaction functional groups, and the polysaccharide derivative and the compound with at least two reaction functional groups generate an adhesive effect through one or more of physical action or chemical reaction; the polysaccharide derivative is polysaccharide substituted by functional groups. The polysaccharide-based tissue adhesive medical adhesive can bear larger tensile force, has faster tissue adhesion time and higher tissue peeling force compared with cyanoacrylate medical adhesive, can realize the rapid adhesion and closure of wounds, has strong adhesion force with tissues after being applied, is not easy to peel, can be suitable for stretched wounds, and can realize effective closure.
Description
Technical Field
The invention belongs to the field of biomedical materials, and relates to polysaccharide-based tissue bonding medical glue and application thereof.
Background
The medical glue is a preparation, material or substance which can be adhered to the surface or cause the adhesion between the surfaces in medical application, is mainly used for local adhesion and repair of organs or tissues and replaces the traditional suture; or the combination and positioning of tissues and blood vessels for plugging and the like. Compared with the traditional methods such as suturing and nailing, the use of the medical adhesive can effectively shorten the operation time and obviously reduce the pain of patients. In tissue bonding, bonding generally involves the following aspects: 1. adhesion between living tissue internal activities; 2. adhesion between the organism and the medical glue; 3. adhesion between medical glues. The important component of the living tissue is protein, so the interaction between the medical glue and the protein is the main force for tissue adhesion. Cyanoacrylate medical adhesives have been rapidly developed and widely used in clinical practice in recent decades. However, the adhesive has the defects of poor impact resistance, low viscosity, poor gap filling performance on porous and rough surfaces, fast in-vivo degradation time, poor heat resistance, poor water resistance and the like, so that the application of the adhesive in medicine is limited to a certain extent.
The ideal medical glue should have the following properties: 1. safe use, asepsis, no toxicity, good biocompatibility, and no interference to the self healing of human tissues; 2. the adhesive can quickly adhere to tissues under physiological conditions, and has good adhesive strength and durability; 3. has certain functions of stopping bleeding and promoting tissue regeneration, and can inhibit bacterial infection; 4. can be degraded and absorbed by the organism within a reasonable time, and the degradation product has no toxic or side effect on the organism; 5. convenient use, easy storage, low price and easy obtainment of raw materials.
Disclosure of Invention
In view of the above, the present invention provides a polysaccharide-based tissue adhesive medical adhesive and applications thereof.
The invention specifically provides the following technical scheme:
1. the polysaccharide-based tissue-adhesive medical adhesive consists of a polysaccharide derivative and a compound with at least two reactive functional groups, wherein the polysaccharide derivative and the compound with at least two reactive functional groups generate an adhesive effect through one or more of physical action or chemical reaction; the polysaccharide derivative is polysaccharide substituted by functional groups.
Furthermore, the polysaccharide-based tissue bonding medical glue can bond tissues of organisms for 5-50 seconds, has a tissue peeling force of 240-400 g/cm and a tensile stress of 5-20 MPa, and can bear a tensile force of at least 500 g.
Further, the polysaccharide is one or more of chitosan, alginate, hyaluronate, starch, agar, cellulose, polyfructose, dextran, pullulan or chondroitin sulfate and derivatives thereof.
Further, the functional group is one or more of aldehyde group, ester group, amino group, imino group, amide group, imide group, sulfhydryl group, disulfide bond, carboxyl group, hydroxyl group, nitro group, alkenyl group, alkynyl group, azido group and halogen group.
Further, the functional group contained in the compound with at least two reactive functional groups is one or more of a halogen group functional group, an oxygen-containing functional group, a nitrogen-containing functional group, a phosphorus-containing functional group or a sulfur-containing functional group.
Further, the oxygen-containing functional group is a hydroxyl group, a carboxyl group, an ester group, an aldehyde group, a ketone group or an epoxy group, the nitrogen-containing functional group is an amino group, an imino group, an amide group, an azido group, an azo group, a cyanate group, an isocyanate group, a nitrate group, a nitrile group, a nitro group or a pyridyl group, the phosphorus-containing functional group is a phosphorus group, a phosphoric acid group or a phosphate group, and the sulfur-containing functional group is a mercapto group, a disulfide bond, a thiol group, a thioether group, a sulfone group or a sulfonic group.
Further, the degree of substitution of the functional group for the polysaccharide is 1% to 90%, and the molar ratio of the polysaccharide derivative to the compound having at least two reactive functional groups is 1: 0.01-1: 100.
further, the molar ratio of the polysaccharide derivative to the compound having at least two reactive functional groups is 1:0.2 to 1: 50.
Further, the polysaccharide derivative is one or more of N-hydroxysuccinimide ester modified glucan, oxidized sodium alginate, polyethylene glycol modified pullulan, oxidized hyaluronic acid, cystamine modified glucan or azide modified glucan; the N-hydroxysuccinimide ester modified glucan knotThe structure formula is as follows:
wherein m is 5-2000, n is 1-1800; the structural formula of the oxidized sodium alginate is as follows:
wherein m is 20-1000, and n is 1-900; the structural formula of the polyethylene glycol modified pullulan polysaccharide is as follows:
wherein m is 15-4000, and n is 1-3600; the oxidized hyaluronic acid has a structural formula:
wherein x is 1-4000, y is 1-3000, and z is 1-4000; the structural formula of the cystamine modified glucan is as follows:
wherein m is 5-2000, n is 1-1800; the structural formula of the azide-modified glucan is as follows:
wherein m is 5-2000, n is 1-1800; the compound with at least two reactive functional groups is one or more of branched polyethyleneimine, dopamine hydrochloride, cyclodextrin, amikacin sulfate, pentaerythritol tetrakis (3-mercaptopropionate), epichlorohydrin, sodium trimetaphosphate or pentaerythritol tetrapropargonate, and the structural formula of the pentaerythritol tetrapropargonate is as follows:
2. use of a polysaccharide-based tissue adhesive medical glue for the adhesion of wound tissue.
The invention has the beneficial effects that: the polysaccharide-based polymer has a molecular structure like a long line, has low strength and is easy to break without crosslinking and has no elasticity by virtue of the adhesive action generated by one or more of the physical action and the chemical action generated by the polysaccharide modified by the functional group and the compound with a plurality of reactive functional groups, and the adhesive action generated by one or more of the physical action and the chemical action generated by the compound with a plurality of reactive functional groups is the action force generated between linear molecules to connect the linear molecules together to form a net structure, so that the strength and the elasticity of the adhesive are improved, and the adhesive action has good biological safety and can be used for tissue adhesion. The powdered polysaccharide-based tissue adhesive medical colloid is fluffy, has good adhesiveness and is easy to use. The gel polysaccharide-based tissue adhesive medical adhesive is easy to use, has high biological safety and strong adhesion with human skin tissues. The polysaccharide-based tissue adhesive medical adhesive can bear larger tension (can bear 500g of tension under the optimized condition), has faster tissue adhesion time and higher tissue peeling force compared with cyanoacrylate medical adhesive, can realize the rapid adhesion and closure of wounds, has strong adhesion force with tissues after application, is not easy to peel, can be suitable for stretched wounds, and can realize effective closure.
Drawings
In order to make the purpose, technical scheme and beneficial effect of the invention more clear, the invention provides the following drawings:
figure 1 shows the application of a powdered polysaccharide-based tissue-adhesive medical glue 1 to fresh pig skin.
Fig. 2 shows the application of the gel-like polysaccharide-based tissue adhesive medical glue 2 to the back of the hands of volunteers.
Figure 3 is a tensile test after bonding of polysaccharide based tissue bonded medical glue 1.
Figure 4 is a polysaccharide-based tissue-adhesive medical glue 3 rat dorsal skin adhesion experiment.
Fig. 5 is a graph of the stress-strain mechanical property test of the polysaccharide-based tissue-adhesive medical glue.
Fig. 6 is a scanning electron microscope image of the cross-linked structure of the polysaccharide-based tissue-adhesive medical glue 5.
Fig. 7 is a gel-forming rheology diagram of polysaccharide-based tissue-adhesive medical gel 3.
Detailed Description
Preferred embodiments of the present invention will be described in detail below with reference to the accompanying drawings.
Example 1
Preparation of polysaccharide-based tissue-adhesive medical adhesive: 2g N-hydroxysuccinimide ester-modified dextran (structural formula:
wherein m is 5-2000, n is 1-1800, degree of substitution 90%) and 0.5g of branched polyethyleneimine are dissolved in 50mL of deionized water, and stirred for 6 hours. Purifying, drying and grinding the mixture by a conventional method to obtain powdery polysaccharide-based tissue adhesive medical glue 1,
example 2
Preparation of polysaccharide-based tissue-adhesive medical adhesive: 2g of oxidized sodium alginate powder (structural formula:
wherein m is 20-1000, n is 1-900, degree of substitution 70%) and 0.8g of dopamine hydrochloride powder to obtain the powdery polysaccharide-based tissue adhesive medical glue 2.
Example 3
Preparation of polysaccharide-based tissue-adhesive medical adhesive: 2g of polyethylene glycol-modified pullulan (structural formula:
wherein m is 15-4000, n is 1-3600, and the substitution degree is 5%) and 0.6g of alpha-cyclodextrin are dissolved in 60mL of deionized water and stirred for 3 hours. Purifying, drying and grinding the mixture by a conventional method to obtain the powdery polysaccharide-based tissue-adhesive medical adhesive 3.
Example 4
Preparation of polysaccharide-based tissue-adhesive medical adhesive: 1g of oxidized hyaluronic acid (structural formula:
wherein x is 1-4000, y is 1-3000, z is 1-4000, the substitution degree is 20 percent), 1g of chitosan and 0.2g of amikacin sulfate are dissolved in 30mL of deionized waterThe gelatinous polysaccharide-based tissue-adhesive medical glue 4 is obtained.
Example 5
Preparation of polysaccharide-based tissue-adhesive medical adhesive: 0.5g of cystamine-modified dextran (structural formula:
wherein m is 5 to 2000, n is 1 to 1800, degree of substitution 68%) and 0.5g of pentaerythritol tetra-3-mercaptopropionate are dissolved in 10mL of deionized water to obtain the gel-like polysaccharide-based tissue adhesive medical adhesive 5.
Example 6
Preparation of polysaccharide-based tissue-adhesive medical adhesive: 1g of azide-modified dextran (structural formula:
wherein m is 5 to 2000, n is 1 to 1800, degree of substitution 1%), 0.5g pentaerythritol tetrapropargonate (structural formula:
) And 2mg copper sulfate (catalyst) in 20mL DMSO, was routinely purified to give waxy polysaccharide-based tissue-binding medical gel 6.
Example 7
Preparation of polysaccharide-based tissue-adhesive medical adhesive: 1g of carboxymethyl chitosan (with a substitution degree of 35 percent) and 2g of epichlorohydrin are dissolved in 50mL of deionized water, heated at 50 ℃ for 12 hours, and subjected to conventional purification, drying and grinding to obtain powdery polysaccharide-based tissue adhesive medical adhesive 7.
Example 8
Preparation of polysaccharide-based tissue-adhesive medical adhesive: 1g hydroxyethyl starch (degree of substitution 18%), 1g sodium trimetaphosphate were dissolved in 50mL deionized water and purified, dried, and ground conventionally to give polysaccharide-based tissue-adhesive medical gel 8 in powder form.
Example 9
Each of the polysaccharide-based tissue-bonded medical adhesive 1-7 samples was applied between two fresh pigskins with a contact area of 2x2cm2, the bonded pigskin was picked up every 10 seconds and a weight of 50g was hung at one end, and the tissue bonding time was recorded as the time taken for the two pigskins to be fully bonded without slipping and able to withstand the weight of 50 g. After 10 minutes of bonding, the sample was peeled at a 90 ° angle and the tissue peel force was recorded in the tensile tester, yielding the data in table 1.
As can be seen from a comparison of the data in table 1: compared with cyanoacrylate medical adhesive, the polysaccharide-based tissue adhesive medical adhesive has the advantages of faster tissue adhesion time and higher tissue peeling force, can realize the rapid adhesion and closure of wounds, and has strong adhesion force with tissues after application and difficult peeling.
TABLE 1
Fig. 1 shows that the powdered polysaccharide-based tissue-adhesive medical gel 1 is applied to fresh pig skin, and it can be seen from fig. 1 that the powdered polysaccharide-based tissue-adhesive medical gel is fluffy, has good adhesiveness, and is easy to use.
Fig. 2 shows that the gel-like polysaccharide-based tissue adhesive medical glue 2 is applied to the back of the hand of a volunteer, and it can be seen from fig. 2 that the gel-like polysaccharide-based tissue adhesive medical glue is easy to use, has high biosafety and strong adhesion with human skin tissue.
Fig. 3 is a tensile test of the polysaccharide-based tissue adhesive medical glue 1 after adhesion, and it can be seen from fig. 3 that the polysaccharide-based tissue adhesive medical glue can bear 500g of tensile force, is suitable for a stretched wound, and can realize effective closure.
Fig. 4 is a polysaccharide-based tissue-adhesive medical adhesive 3 rat dorsal skin adhesion experiment, and it can be seen from fig. 4 that the polysaccharide-based tissue-adhesive medical adhesive can be widely used for closing wounds of biological tissues and has high biological safety.
Fig. 5 is a stress-strain mechanical property test of the polysaccharide-based tissue bonding medical adhesive, wherein curves 1 to 5 from left to right in the graph respectively represent stress-strain curves of the polysaccharide-based tissue bonding medical adhesive 6, the polysaccharide-based tissue bonding medical adhesive 4, the polysaccharide-based tissue bonding medical adhesive 7, the polysaccharide-based tissue bonding medical adhesive 8 and the polysaccharide-based tissue bonding medical adhesive 2, and can be seen from fig. 5: the polysaccharide-based tissue bonding medical adhesive has the tensile strength ranging from 5.8 MPa to 14.1MPa after bonding, which shows that the polysaccharide-based tissue bonding medical adhesive has higher tensile strength and can generate stronger bonding effect.
Fig. 6 is a scanning electron microscope image of the cross-linked structure of the polysaccharide-based tissue-adhesive medical glue 5. As can be seen from fig. 6, the polysaccharide-based tissue-binding medical glue allows linear molecules to be attached to each other to form a network structure, which improves the strength and elasticity of the adhesive.
Fig. 7 is a gel-forming rheology diagram of polysaccharide-based tissue-adhesive medical gel 3. It can be seen from fig. 7 that the faster gel time (only 30 seconds) of the powdered polysaccharide-based tissue-adhesive medical glue allows for rapid adhesion.
Finally, it is noted that the above-mentioned preferred embodiments illustrate rather than limit the invention, and that, although the invention has been described in detail with reference to the above-mentioned preferred embodiments, it will be understood by those skilled in the art that various changes in form and detail may be made therein without departing from the scope of the invention as defined by the appended claims.
Claims (6)
1. The polysaccharide-based tissue-adhesive medical adhesive is characterized by consisting of a polysaccharide derivative and a compound with at least two reactive functional groups, wherein the polysaccharide derivative and the compound with at least two reactive functional groups generate an adhesive effect through one or more of physical action or chemical reaction; the polysaccharide derivative is polysaccharide substituted by functional groups; the functional group is polyethylene glycol, the functional group is cyclodextrin, the tissue adhesion time of the polysaccharide-based tissue adhesion medical adhesive to an organism is 5-50 seconds, the tissue peeling force is 240-400 g/cm, the tensile stress is 5-20 MPa, and the medical adhesive can bear the tensile force of at least 500 g.
2. The polysaccharide-based tissue-adhesive medical glue of claim 1, wherein the polysaccharide comprises one or more of chitosan, alginate, hyaluronate, starch, agar, cellulose, polyfructose, dextran, pullulan, chondroitin sulfate and derivatives thereof.
3. The polysaccharide-based tissue-adhesive medical glue of claim 1, wherein the polysaccharide derivative is polyethylene glycol-modified pullulan having the structural formula:
wherein m is 15-4000 and n is 1-3600.
4. The polysaccharide-based tissue-adhesive medical glue of claim 1, wherein said compound having at least two reactive functional groups is α -cyclodextrin.
5. The polysaccharide-based tissue-adhesive medical glue of claim 1, wherein the degree of substitution of component 1 is 1% to 90%, and the molar ratio of component 1 to component 2 is 1: 0.01-1: 100.
6. use of the polysaccharide based tissue adhesive medical glue according to any one of claims 1-5 for the adhesion of wound tissue.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110160412.1A CN112957516B (en) | 2018-08-20 | 2018-08-20 | Polysaccharide-based tissue adhesive medical adhesive and application thereof |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810945722.2A CN108926736A (en) | 2018-08-20 | 2018-08-20 | Polysaccharide-based tissue adhesion medical adhesive and its application |
| CN202110160412.1A CN112957516B (en) | 2018-08-20 | 2018-08-20 | Polysaccharide-based tissue adhesive medical adhesive and application thereof |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810945722.2A Division CN108926736A (en) | 2018-08-20 | 2018-08-20 | Polysaccharide-based tissue adhesion medical adhesive and its application |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN112957516A true CN112957516A (en) | 2021-06-15 |
| CN112957516B CN112957516B (en) | 2022-08-09 |
Family
ID=64445977
Family Applications (8)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110160360.8A Active CN112957518B (en) | 2018-08-20 | 2018-08-20 | Polysaccharide-based tissue adhesive medical adhesive and application thereof |
| CN202110160412.1A Active CN112957516B (en) | 2018-08-20 | 2018-08-20 | Polysaccharide-based tissue adhesive medical adhesive and application thereof |
| CN202110159805.0A Active CN112807479B (en) | 2018-08-20 | 2018-08-20 | Polysaccharide-based tissue adhesive medical adhesive and application thereof |
| CN202110167181.7A Active CN112807482B (en) | 2018-08-20 | 2018-08-20 | Polysaccharide-based tissue adhesive medical adhesive and application thereof |
| CN202110160381.XA Active CN112807480B (en) | 2018-08-20 | 2018-08-20 | Polysaccharide-based tissue adhesive medical adhesive and application thereof |
| CN201810945722.2A Pending CN108926736A (en) | 2018-08-20 | 2018-08-20 | Polysaccharide-based tissue adhesion medical adhesive and its application |
| CN202110159804.6A Active CN112807478B (en) | 2018-08-20 | 2018-08-20 | Polysaccharide-based tissue adhesive medical adhesive and application thereof |
| CN202110160406.6A Active CN112807481B (en) | 2018-08-20 | 2018-08-20 | Medical polysaccharide-based tissue adhesion glue and application thereof |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110160360.8A Active CN112957518B (en) | 2018-08-20 | 2018-08-20 | Polysaccharide-based tissue adhesive medical adhesive and application thereof |
Family Applications After (6)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110159805.0A Active CN112807479B (en) | 2018-08-20 | 2018-08-20 | Polysaccharide-based tissue adhesive medical adhesive and application thereof |
| CN202110167181.7A Active CN112807482B (en) | 2018-08-20 | 2018-08-20 | Polysaccharide-based tissue adhesive medical adhesive and application thereof |
| CN202110160381.XA Active CN112807480B (en) | 2018-08-20 | 2018-08-20 | Polysaccharide-based tissue adhesive medical adhesive and application thereof |
| CN201810945722.2A Pending CN108926736A (en) | 2018-08-20 | 2018-08-20 | Polysaccharide-based tissue adhesion medical adhesive and its application |
| CN202110159804.6A Active CN112807478B (en) | 2018-08-20 | 2018-08-20 | Polysaccharide-based tissue adhesive medical adhesive and application thereof |
| CN202110160406.6A Active CN112807481B (en) | 2018-08-20 | 2018-08-20 | Medical polysaccharide-based tissue adhesion glue and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (8) | CN112957518B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116370687B (en) * | 2023-06-01 | 2023-08-04 | 四川大学 | First-aid hemostatic tissue patch based on acrylic acid copolymer and preparation method thereof |
Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1910219A (en) * | 2004-01-08 | 2007-02-07 | 国立大学法人东京大学 | Crosslinked polyrotaxane and process for producing the same |
| JPWO2008084705A1 (en) * | 2007-01-09 | 2010-04-30 | 国立大学法人金沢大学 | Process for producing anhydrosugars in ionic liquids |
| CN102438666A (en) * | 2009-04-09 | 2012-05-02 | 阿克塔马克斯手术器材有限责任公司 | Hydrogel tissue adhesive having reduced degradation time |
| CN105778124A (en) * | 2012-09-28 | 2016-07-20 | 山东赛克赛斯药业科技有限公司 | Biodegradable medicine hydrogel and preparation method and application thereof |
| CN105979976A (en) * | 2013-12-10 | 2016-09-28 | 法国国家健康医学研究院 | Methods for adhering tissue surfaces and materials and biomedical uses thereof |
| CN106075549A (en) * | 2016-06-17 | 2016-11-09 | 广州迈普再生医学科技有限公司 | Tissue closes glue composition, and tissue closes glue and its preparation method and application |
| CN106075550A (en) * | 2016-06-17 | 2016-11-09 | 广州迈普再生医学科技有限公司 | Medical tissue closes glue composition, and medical tissue closes glue and its preparation method and application |
| CN106519264A (en) * | 2016-11-10 | 2017-03-22 | 中国科学院化学研究所 | Double-network hydrogel based on PEG (polyethylene glycol) and polysaccharides as well as preparation method and application of double-network hydrogel |
| US20170281781A1 (en) * | 2016-04-01 | 2017-10-05 | Ajou University Industry-Academic Cooperation Foun Dation | Injectable tissue adhesive hydrogel including gamma-cyclodextrin and biomedical use thereof |
| CN107384306A (en) * | 2017-08-22 | 2017-11-24 | 杭州易敏生物医药科技有限公司 | Bioadhesive and its preparation method and application |
Family Cites Families (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8200751L (en) * | 1982-02-09 | 1983-08-10 | Olle Larm | PROCEDURE FOR COVALENT COUPLING FOR MANUFACTURE OF CONJUGATE AND REQUIRED PRODUCTS |
| DE19521324C1 (en) * | 1995-06-12 | 1996-10-31 | Immuno Ag | Tissue adhesive and use thereof as a hemostatic |
| US6833408B2 (en) * | 1995-12-18 | 2004-12-21 | Cohesion Technologies, Inc. | Methods for tissue repair using adhesive materials |
| JP4193917B2 (en) * | 1995-12-18 | 2008-12-10 | アンジオデバイス インターナショナル ゲーエムベーハー | Crosslinked polymer composition and method of use thereof |
| GB9902412D0 (en) * | 1999-02-03 | 1999-03-24 | Fermentech Med Ltd | Process |
| GB9902652D0 (en) * | 1999-02-05 | 1999-03-31 | Fermentech Med Ltd | Process |
| US20040101548A1 (en) * | 2002-11-26 | 2004-05-27 | Pendharkar Sanyog Manohar | Hemostatic wound dressing containing aldehyde-modified polysaccharide |
| CN1756530A (en) * | 2002-12-30 | 2006-04-05 | 血管技术国际股份公司 | Drug delivery from rapid gelling polymer composition |
| WO2004081055A1 (en) * | 2003-02-21 | 2004-09-23 | Terumo Kabushiki Kaisha | Crosslinkable polysaccharide derivative, process for producing the same, crosslinkable polysaccharide composition and medical treatment material |
| BRPI0510477B1 (en) * | 2004-04-28 | 2023-01-17 | Angiotech Biomaterials Corporation | METHOD FOR FORMING A GEL AND DEVICE FOR USE IN MEDICAL APPLICATIONS |
| MXPA06013721A (en) * | 2004-05-27 | 2007-04-17 | Univ Pittsburgh | Medical adhesive and methods of tissue adhesion. |
| DE102007038125A1 (en) * | 2007-08-03 | 2009-02-05 | Aesculap Ag | Combination for bonding biological tissues |
| US20090035350A1 (en) * | 2007-08-03 | 2009-02-05 | John Stankus | Polymers for implantable devices exhibiting shape-memory effects |
| US8846095B2 (en) * | 2007-11-14 | 2014-09-30 | Actamax Surgical Materials, Llc | Dextran-based polymer tissue adhesive for medical use |
| EP2214731B1 (en) * | 2007-11-14 | 2014-05-14 | Actamax Surgical Materials LLC | Oxidized cationic polysaccharide-based polymer tissue adhesive for medical use |
| US8034396B2 (en) * | 2008-04-01 | 2011-10-11 | Tyco Healthcare Group Lp | Bioadhesive composition formed using click chemistry |
| US8663689B2 (en) * | 2009-02-21 | 2014-03-04 | Sofradim Production | Functionalized adhesive medical gel |
| ES2593584T3 (en) * | 2009-05-28 | 2016-12-09 | Profibrix Bv | Dry powder fibrin sealant |
| CN101716366A (en) * | 2009-12-17 | 2010-06-02 | 天津大学 | Biocolloid hemostatic prepared by aldehyde-modified sodium alginate and amine-modified gelatine |
| CN102002117B (en) * | 2010-10-21 | 2012-10-17 | 中山大学 | Branched chitosan derivative and preparation method thereof |
| CN102247617A (en) * | 2011-07-01 | 2011-11-23 | 莫秀梅 | Medical adhesive or hemostatic |
| WO2013030840A2 (en) * | 2011-09-01 | 2013-03-07 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Adhesive biopolymers and uses thereof |
| US10765774B2 (en) * | 2013-07-09 | 2020-09-08 | Ethicon, Inc. | Hemostatic pad assembly kit and method |
| EP3027659B1 (en) * | 2013-07-29 | 2020-12-09 | Actamax Surgical Materials LLC | Low swell tissue adhesive and sealant formulations |
| KR101664444B1 (en) * | 2013-12-13 | 2016-10-12 | 재단법인 유타 인하 디디에스 및 신의료기술개발 공동연구소 | Biodegradable medical adhesive or sealant compositions |
| CN103800937B (en) * | 2014-02-25 | 2015-06-03 | 西南交通大学 | Method for preparing dressing for injured part of skin and mucosa |
| CN104892962B (en) * | 2015-06-05 | 2017-12-08 | 四川大学 | A kind of preparation method and applications of the controllable self-crosslinking hyaluronic acid gel of sulfydryl/disulfide bond |
| FR3038318B1 (en) * | 2015-07-02 | 2017-08-04 | Univ De Lille 1 Sciences Et Technologies | PROCESS FOR THE PRODUCTION OF CHITOSAN-BASED HYDROGEL AND NEGATIVELY LOADED POLYELECTROLYTES AND POROUS ALVEOLAR MATERIALS FROM SAID HYDROGEL |
| CN105126157B (en) * | 2015-09-17 | 2018-02-09 | 爱美客技术发展股份有限公司 | Medical injectable adhesive gel and preparation method thereof |
| CA3005026A1 (en) * | 2015-11-11 | 2017-05-18 | Ethicon, Inc. | Sealant formulation and uses thereof |
| CN105327388B (en) * | 2015-12-07 | 2018-10-26 | 莫秀梅 | A kind of adhesive of medical and preparation method thereof |
| CN105477678B (en) * | 2015-12-25 | 2019-01-29 | 四川大学 | A kind of new bio adhesive of medical and preparation method thereof |
| CN105770981A (en) * | 2016-03-09 | 2016-07-20 | 四川大学 | Biological medical oxidative sodium carboxymethylcellulose-dopamine adhesive and preparation method thereof |
| CN106075553A (en) * | 2016-07-12 | 2016-11-09 | 四川大学 | A kind of bio-medical binding agent and preparation method thereof |
| CN106178089A (en) * | 2016-07-21 | 2016-12-07 | 青岛中腾生物技术有限公司 | A kind of medical toughness closes hemostatic material and compositions |
| CN107754005B (en) * | 2016-08-15 | 2021-06-15 | 广州倍绣生物技术有限公司 | Hemostatic compositions and methods of making same |
| CN106310356A (en) * | 2016-08-24 | 2017-01-11 | 深圳尼罗河生物科技有限公司 | Materials for bioresorbable hydroxyethyl cellulose powder adhesive and preparing method thereof |
| CN106581734A (en) * | 2016-11-22 | 2017-04-26 | 孙祎 | Preparation method of highly antibacterial alginate dressing |
| CN106750249B (en) * | 2016-12-26 | 2019-09-13 | 深圳迈普再生医学科技有限公司 | Medical aquogel precursor and preparation method thereof and medical aquogel and application |
| CN106620825B (en) * | 2016-12-26 | 2019-11-12 | 浙江大学 | A kind of bi-component quick-acting haemostatic powder gel and its application |
| CN106975097A (en) * | 2017-03-02 | 2017-07-25 | 四川大学 | A kind of bio-medical bonding hydrogel and preparation method thereof |
| CN106975098B (en) * | 2017-04-13 | 2020-07-07 | 赛克赛斯生物科技股份有限公司 | Composite polysaccharide hemostatic composition and preparation method and application thereof |
| CN107158453B (en) * | 2017-06-02 | 2020-02-18 | 武汉纺织大学 | Preparation method of hyaluronic acid tissue adhesive |
| CN107213509B (en) * | 2017-06-08 | 2019-08-02 | 北京化工大学 | A kind of styptic powder and preparation method thereof |
| CN107325306B (en) * | 2017-06-13 | 2019-10-25 | 爱美客技术发展股份有限公司 | The multiple cross-linked gel of chitosan or derivatives thereof and preparation method |
| CN107474128B (en) * | 2017-09-15 | 2019-03-22 | 中国海洋大学 | A kind of bionical hemostasis biogum |
| CN107496974B (en) * | 2017-10-10 | 2021-04-02 | 东华大学 | Two-component medical adhesive based on glucan and chitosan and preparation method thereof |
| CN107899078A (en) * | 2017-10-26 | 2018-04-13 | 华南理工大学 | A kind of method in three-dimensional rack surface covalent bonding bioactive layer |
| CN108159482A (en) * | 2018-01-02 | 2018-06-15 | 上海其胜生物制剂有限公司 | A kind of injectable natural hydrogel system with temperature-sensing property and high bioadhesion and preparation method thereof |
| CN108314790A (en) * | 2018-03-16 | 2018-07-24 | 东华大学 | A kind of photo-crosslinking thio chitosan-polyethylene glycol methacrylate-styrene polymer hydrogel and preparation method thereof for tissue adhesive |
-
2018
- 2018-08-20 CN CN202110160360.8A patent/CN112957518B/en active Active
- 2018-08-20 CN CN202110160412.1A patent/CN112957516B/en active Active
- 2018-08-20 CN CN202110159805.0A patent/CN112807479B/en active Active
- 2018-08-20 CN CN202110167181.7A patent/CN112807482B/en active Active
- 2018-08-20 CN CN202110160381.XA patent/CN112807480B/en active Active
- 2018-08-20 CN CN201810945722.2A patent/CN108926736A/en active Pending
- 2018-08-20 CN CN202110159804.6A patent/CN112807478B/en active Active
- 2018-08-20 CN CN202110160406.6A patent/CN112807481B/en active Active
Patent Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1910219A (en) * | 2004-01-08 | 2007-02-07 | 国立大学法人东京大学 | Crosslinked polyrotaxane and process for producing the same |
| JPWO2008084705A1 (en) * | 2007-01-09 | 2010-04-30 | 国立大学法人金沢大学 | Process for producing anhydrosugars in ionic liquids |
| CN102438666A (en) * | 2009-04-09 | 2012-05-02 | 阿克塔马克斯手术器材有限责任公司 | Hydrogel tissue adhesive having reduced degradation time |
| CN105778124A (en) * | 2012-09-28 | 2016-07-20 | 山东赛克赛斯药业科技有限公司 | Biodegradable medicine hydrogel and preparation method and application thereof |
| CN105979976A (en) * | 2013-12-10 | 2016-09-28 | 法国国家健康医学研究院 | Methods for adhering tissue surfaces and materials and biomedical uses thereof |
| US20170281781A1 (en) * | 2016-04-01 | 2017-10-05 | Ajou University Industry-Academic Cooperation Foun Dation | Injectable tissue adhesive hydrogel including gamma-cyclodextrin and biomedical use thereof |
| CN106075549A (en) * | 2016-06-17 | 2016-11-09 | 广州迈普再生医学科技有限公司 | Tissue closes glue composition, and tissue closes glue and its preparation method and application |
| CN106075550A (en) * | 2016-06-17 | 2016-11-09 | 广州迈普再生医学科技有限公司 | Medical tissue closes glue composition, and medical tissue closes glue and its preparation method and application |
| CN106519264A (en) * | 2016-11-10 | 2017-03-22 | 中国科学院化学研究所 | Double-network hydrogel based on PEG (polyethylene glycol) and polysaccharides as well as preparation method and application of double-network hydrogel |
| CN107384306A (en) * | 2017-08-22 | 2017-11-24 | 杭州易敏生物医药科技有限公司 | Bioadhesive and its preparation method and application |
Non-Patent Citations (3)
| Title |
|---|
| HUH KM: "Supramolecular-structured hydrogels showing a reversible phase transition by inclusion complexation between poly(ethylene glycol) grafted dextran and alpha-cyclodextrin", 《MACROMOLECULES》 * |
| VIPUL D. PRAJAPATI: "Pullulan：an exopolysaccharide and its various applications", 《CARBOHYDR POLYM.》 * |
| 张振琳: "普鲁兰多糖的改性及应用研究进展", 《燕山大学学报》 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN108926736A (en) | 2018-12-04 |
| CN112807481B (en) | 2022-07-26 |
| CN112957518B (en) | 2022-10-25 |
| CN112807478A (en) | 2021-05-18 |
| CN112807481A (en) | 2021-05-18 |
| CN112807478B (en) | 2022-08-02 |
| CN112807479B (en) | 2022-08-05 |
| CN112807482A (en) | 2021-05-18 |
| CN112957518A (en) | 2021-06-15 |
| CN112807482B (en) | 2022-07-29 |
| CN112807480B (en) | 2022-08-09 |
| CN112807479A (en) | 2021-05-18 |
| CN112957516B (en) | 2022-08-09 |
| CN112807480A (en) | 2021-05-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sanandiya et al. | Tunichrome-inspired pyrogallol functionalized chitosan for tissue adhesion and hemostasis | |
| CN107496974B (en) | Two-component medical adhesive based on glucan and chitosan and preparation method thereof | |
| CN106390185A (en) | Preparation method of biological mimetic tissue adhesive | |
| CN105327388B (en) | A kind of adhesive of medical and preparation method thereof | |
| JP4606586B2 (en) | Functional chitosan derivatives | |
| Ono et al. | Photocrosslinkable chitosan as a biological adhesive | |
| JPS61253065A (en) | Medical composite material of chitosan derivative and collagen and its production | |
| AU2020331035B2 (en) | Tissue repair membrane adapted for adhesion and lubrication, and methods for preparing the same | |
| Yang et al. | Advances in adhesive hydrogels for tissue engineering | |
| WO2004081055A1 (en) | Crosslinkable polysaccharide derivative, process for producing the same, crosslinkable polysaccharide composition and medical treatment material | |
| JP4585743B2 (en) | Biodegradable absorbable adhesive medical material | |
| CN111499874B (en) | Sulfhydrylated cholesterol modified mPEG grafted chitosan and preparation method and application thereof | |
| CN112807480B (en) | Polysaccharide-based tissue adhesive medical adhesive and application thereof | |
| CN114917400B (en) | Polylysine antibacterial tissue adhesive and application thereof | |
| Wang et al. | Mussel‐mimetic chitosan based injectable hydrogel with fast-crosslinking and water-resistance as tissue adhesive | |
| CN110694099B (en) | Mytilus edulis bionic adhesive based on polymalic acid and preparation method and application thereof | |
| Chen et al. | Injectable Dopamine–Polysaccharide In Situ Composite Hydrogels with Enhanced Adhesiveness | |
| Zhang et al. | An injectable, robust double network adhesive hydrogel for efficient, real-time hemostatic sealing | |
| Huang et al. | Natural polymer-based bioadhesives as hemostatic platforms for wound healing | |
| WO2010070458A2 (en) | Polysaccharide-based adhesive | |
| CN110408038B (en) | Performance-controllable shell oligosaccharide-based biological adhesive and preparation method thereof | |
| WO2023157150A1 (en) | Use of polysaccharide derivative | |
| JPH0622580B2 (en) | Medical material composed of succinyl chitosan | |
| Ashrafi et al. | Engineering a mussel-inspired hemostatic sealant with a strong tissue anchor as a first-aid tissue adhesive | |
| JP2023161851A (en) | Adhesive, wound covering material, accretion prevention material, hemostatic material, sealant, and spray kit |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |